Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)
Neurology·MeSH: Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)?
There are 1 clinical trial targeting Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD) tracked by BioSniper.
What is the prevalence of Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)?
The estimated prevalence of Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD) is approximately 0.1 per 100,000 population.
Deep-dive into Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis